Viyash Scientific · NSE: VIYASH · BSE: 512529
Q3 FY21 results · Oct–Dec 2020
Viyash Scientific reported revenue from operations of ₹358.21 crore (up 13.2% from Q3 FY20) and net profit of ₹39.69 crore (up 65.0% from Q3 FY20) for Q3 FY21 (Oct–Dec 2020), on a consolidated basis.
| Item | Q3 FY21 | Q3 FY20 | YoY | Q2 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 358.21 | 316.42 | +13.2% | 346.27 | +3.4% |
| Other income | 2.81 | 0.98 | +186.2% | 2.63 | +6.6% |
| Total income | 361.02 | 317.40 | +13.7% | 348.91 | +3.5% |
| Profit before tax | 51.33 | 28.31 | +81.3% | 29.32 | +75.0% |
| Net profit for the period | 39.69 | 24.06 | +65.0% | 21.36 | +85.8% |
| Attributable to shareholders of the company | 37.23 | 20.30 | +83.3% | 21.26 | +75.1% |
| EPS, basic (₹) | 1.52 | 0.83 | +83.1% | 0.86 | +76.7% |
| Net margin (%) | 11.1 | 7.6 | 6.2 |
| Item | Q3 FY21 | Q3 FY20 | YoY | Q2 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 70.57 | 61.80 | +14.2% | 69.64 | +1.3% |
| Other income | 5.67 | 2.11 | +168.2% | 6.10 | −7.1% |
| Total income | 76.24 | 63.91 | +19.3% | 75.74 | +0.7% |
| Profit before tax | 16.11 | 4.69 | +243.4% | 11.03 | +46.0% |
| Net profit for the period | 12.17 | 2.92 | +317.0% | 9.21 | +32.1% |
| EPS, basic (₹) | 0.50 | 0.12 | +316.7% | 0.37 | +35.1% |
| Net margin (%) | 17.2 | 4.7 | 13.2 |
Consolidated
- Filed with BSE
- 04 Feb 2021, 14:53 IST
- Board meeting
- 03 Feb 2021
- Period
- 01 Oct 2020 to 31 Dec 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 04 Feb 2021, 14:53 IST
- Board meeting
- 03 Feb 2021
- Period
- 01 Oct 2020 to 31 Dec 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE